Asbcopal effects after conventional and stereotactic lung irradiation of non-small-cell lung cancer

Journal of Thoracic Oncology

Volumn 8, Issue 8, 2013, Pages

  Siva, Shankar ^a,b   Callahan, Jason ^b   Macmanus, Michael P ^b   Martin, Olga ^b   Hicks, Rodney J ^b   Ball, David L ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; PACLITAXEL; FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT;

ADRENAL METASTASIS; AGED; CANCER RADIOTHERAPY; CANCER STAGING; CASE REPORT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DRUG EFFECT; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; METABOLISM; PRIORITY JOURNAL; RADIATION DOSE; SHORT SURVEY; STEREOTACTIC BODY RADIATION THERAPY; CARCINOMA, NON-SMALL-CELL LUNG; IMMUNOLOGY; LUNG NEOPLASMS; PATHOLOGY; PROCEDURES; RADIOSURGERY; ARTICLE; LUNG TUMOR; METHODOLOGY;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; RADIOSURGERY;

EID: 84880911204     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e318292c55a     Document Type: Article

References (6)

1. Kaminski JM, Shinohara E, Summers JB, Niermann KJ, Morimoto A, Brousal J. The controversial abscopal effect. Cancer Treat Rev 2005;31:159-172.
2. Rees GJ, Ross CM. Abscopal regression following radiotherapy for adenocarcinoma. Br J Radiol 1983;56:63-66.
3. Mole RH. Whole body irradiation; radiobiology or medicine? Br J Radiol 1953;26:234-241.
4. Ghiringhelli F, Apetoh L, Tesniere A, et al. Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat Med 2009;15:1170-1178.
5. Lee Y, Auh SL, Wang Y, et al. Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment. Blood 2009;114:589-595.
6. Wersäll PJ, Blomgren H, Pisa P, Lax I, Kälkner KM, Svedman C. Regression of non-irradiated metastases after extracranial stereotactic radiotherapy in metastatic renal cell carcinoma. Acta Oncol 2006;45:493-497.